Novavax partners with Paragon, sells equipment for $18M

A Maryland biotechnology firm has sold some equipment and other assets to the Baltimore-based gene therapy unit of a New Jersey firm for roughly $18 million and both firms are planning to work together in the future.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *